Insider trades
Kristian Reich, Chief Officer of MoonLake Immunotherapeutics MLTX, has filed 0 purchases and 19 sales on the open market. Over the past 12 months that comes to a net sale of $5.9M. The latest trade was on 06/17.
Kristian Reich
Chief Scientific Officer
- First filing
- 23/04/07
- Trades
- 42 trades
- Buys / sales
- 0 / 19
- 12-month net buying
- −$5.9M
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MLTX | Open-market sale10b5-1 plan | 06/15–06/17 | 06/17 | 150,000 sh3 trades | $19.01avg. | $2,851,000 | −5.0% |
MLTX | Open-market sale | 25/12/08–25/12/09 | 25/12/10 | 202,908 sh2 trades | $14.85avg. | $3,012,462.44 | −100.0% |
MLTX | Open-market sale10b5-1 plan | 24/02/27–24/02/28 | 24/02/29 | 118,922 sh4 trades | $55.00avg. | $6,540,710 | No record |
MLTX | Open-market sale10b5-1 plan | 24/02/20–24/02/21 | 24/02/22 | 21,078 sh4 trades | $57.33avg. | $1,208,418.49 | No record |
MLTX | Open-market sale10b5-1 plan | 24/02/14–24/02/16 | 24/02/16 | 60,000 sh6 trades | $60.91avg. | $3,654,800 | No record |